Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Public ClinicalTrials.gov record NCT07258290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the safety and efficacy of the Freesolve resorbable magnesium scaffold (RMS) in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to the Xience coronary drug-eluting stent (DES) system
Study identification
- NCT ID
- NCT07258290
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 1,859 participants
Conditions and interventions
Conditions
- Acute Coronary Syndrome
- Angina Pectoris
- Arterial Occlusive Diseases
- Arteriosclerosis
- Cardiovascular Diseases
- Chest Pain
- Coronary Artery Disease
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia
- Neurologic Manifestations
- Pain
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Vascular Diseases
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2026
- Primary completion
- May 31, 2029
- Completion
- May 31, 2033
- Last update posted
- Jul 23, 2026
2026 – 2033
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MedStar Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Charleston Area Medical Center | Charleston | West Virginia | 25304 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acute Coronary Syndrome trials
Other public records listing Acute Coronary Syndrome. Sorted by last update posted; newest first. Not a recommendation.
- NCT07032389: A Polypill for Acute Coronary Syndrome Recruiting
- NCT05918861: Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS Recruiting
- NCT05412862: Positive Emotions Following Acute Cardiac Events Recruiting
- NCT05699642: Online Tai Chi Plus Fitbit After ACS Active, not recruiting
- NCT04617834: Enhancing Rural Health Via Cardiovascular Telehealth for Rural Patients Implementation (E-VICTORS) Active, not recruiting
- NCT06481943: A Prospective Research Investigation of Ischemia Using MCG Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07258290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2026 · Synced Jul 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07258290 live on ClinicalTrials.gov.